02/14/2025
5:04 PM | Trevi Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
10:21 AM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Trevi Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/13/2025
12:41 PM | Rosalind Advisors, Inc. (Filed by)
Trevi Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/08/2025
7:00 AM | Trevi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2024
3:30 PM | Galletta Christopher (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
4:20 PM | Trevi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
4:18 PM | Trevi Therapeutics (Filer)
| Form 424B5 | |
12/12/2024
7:00 AM | Trevi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
4:20 PM | Trevi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:51 PM | Trevi Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G/A | |
11/13/2024
3:30 PM | Rubric Capital Management LP (Filed by)
Trevi Therapeutics (Subject)
| Form SC 13G/A | |
Get the Latest News and Ratings for TRVI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Trevi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/08/2024
5:57 PM | New Enterprise Associates 16, L.P. (Filed by)
Trevi Therapeutics (Subject)
| Form SC 13D/A | |
11/06/2024
3:20 PM | Trevi Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
9:30 AM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Trevi Therapeutics (Subject)
| Form SC 13G/A | |
10/23/2024
1:44 PM | Rosalind Advisors, Inc. (Filed by)
Trevi Therapeutics (Subject)
| Form SC 13G/A | |
10/21/2024
9:43 AM | Trevi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
7:07 AM | Trevi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
4:00 PM | GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:54 PM | GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:37 PM | GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
3:55 PM | Meeker David P (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:10 PM | Meeker David P (Reporting)
Trevi Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2024
4:14 PM | SCIASCIA THOMAS (Reporting)
Trevi Therapeutics (Subject)
| Form 144/A | |
07/11/2024
4:52 PM | Rosalind Advisors, Inc. (Filed by)
Trevi Therapeutics (Subject)
| Form SC 13G/A | |
07/10/2024
3:16 PM | MAI Capital Management (Filed by)
Trevi Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
06/14/2024
3:40 PM | Mathers Edward T (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:30 PM | Colangelo Dominick (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:30 PM | Trevi Therapeutics (Issuer)
VANLENT ANNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:30 PM | Meeker David P (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:30 PM | Heffernan Michael Thomas (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:30 PM | Cassella James V (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:34 PM | New Enterprise Associates 16, L.P. (Filed by)
Trevi Therapeutics (Subject)
| Form SC 13D/A | |
05/14/2024
3:51 PM | GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:09 PM | Trevi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
6:39 PM | Rosalind Advisors, Inc. (Filed by)
Trevi Therapeutics (Subject)
| Form SC 13G/A | |
03/20/2024
3:08 PM | Trevi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
3:10 PM | Trevi Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/20/2024
3:12 PM | Trevi Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Free TRVI Stock Alerts